CAS NO: | 666260-75-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | GW842166X is a potent and selectivecannabinoid receptor2(CB2) agonist withIC50values of 63 and 91 nM for human and ratCB2, respectively. | ||||||||||||||||
IC50& Target | IC50: 63 nM (human CB2), 91 nM (rat CB2)[1] | ||||||||||||||||
体外研究 (In Vitro) | GW842166X shows similar potency and efficacy for rat and human recombinant CB2 receptors. It has no significant agonist activity at concentrations up to 30 μM in human and rat CB1 recombinant assays[1]. | ||||||||||||||||
体内研究 (In Vivo) | GW842166X has an oral ED50of 0.1 mg/kg in the rat FCA model of inflammatory pain and shows full reversal of hyperalgesia at 0.3 mg/kg. The blood concentrations of GW842166X in experiments are 30 nM (0.03 mg/kg), 130 nM (0.1 mg/kg), and 370 nM (0.3 mg/ kg) 1 h after dosing. After dosing for 4 days in the FCA model, no statistical difference in antihyperalgesic response is observed on day 4 relative to day 1, indicating that tolerance does not occur[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 449.25 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C18H17Cl2F3N4O2 | ||||||||||||||||
CAS 号 | 666260-75-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 83.3 mg/mL(185.42 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|